CEO Andrew Simpson on what’s ahead and how we’re applying advanced science and artificial intelligence to the ECG to make it a much more valuable screening tool

January 31, 2023

To see the video, follow the link: https://proactiveinvestors.com/companies/news/1004693/heartsciences-using-technology-to-help-make-lifesaving-ecg-s-better-using-artificial-intelligence-1004693.html?viewSource=SkyAlphabet

Contacts

MEDIA RELATIONS

Gene Gephart
Director of Marketing
+1-682-244-2578 (US)

INVESTOR CONTACT

Vivian Cervantes
Gilmartin Group

info@heartsciences.com
+1-682-244-2578
Ext. 2024 
550 Reserve Street, Suite 360
Southlake, TX 76092 USA

Certifications

©2024 ™ Trademark of HeartSciences.
 Reg. US Pat. & TM off.
All Rights Reserved.

HeartSciences’ AI-ECG products are currently in development and not commercially available in the United States.

wavECG and wavEKG are trademarks of HeartSciences.
MV-WBSTE-002 Rev A